Objectives of the Oncology Committee are:
Scope of the Oncology Committee is:
The Oncology Committee contributes an article describing its activities for the Compass and submits review articles for the Therapeutic Drug Monitoring journal. The Committee proposes a scientific session at each IATDMCT Congress and at discipline-related conferences. The Committee also initiates to develop a consensus guideline for implementationof TDM in oncology.
At the IATDMCT Rotterdam Congress, the committee formally commences its activities with the first committee meeting, 1 plenary lecture (TDM for oncology: a new scientific committee), 3 symposia (Introductory session "Best Practice: TDM in oncology", TDM in Hemato-oncology and TDM in Solid Tumors), and 2 roundtable discussions (How to utilize the UGT1A1 genotype testing for individualized Irinotecan dosage and Challenges in implementing oncology TDM in practice: Cultural, pre-analytical and logistical issues).
We sincerely invite IATDMCT members who are interested in oncology to attend these sessions.
Please join us!